[8-K] Mine Safety Incorporated Reports Material Event
Scotts Miracle-Gro (SMG) 鈥� Form 144 filing: An affiliate plans to sell up to 70,000 common shares, equal to roughly 0.12% of the 57.7 million shares outstanding. The proposed sale, valued at about $4.35 million, is to be executed through Merrill Lynch on the NYSE around 04 Aug 2025.
The shares were originally obtained on 16 Jun 1995 via a partnership contribution. No shares have been sold by the filer in the last three months. The filer certifies that no undisclosed material adverse information is known.
Because the notice covers secondary stock already in issue, there is no dilution to existing holders. However, the transaction may signal the holder鈥檚 desire to reduce exposure; investors may watch forthcoming Form 4s for additional insider activity.
Scotts Miracle-Gro (SMG) 鈥� Comunicazione Modulo 144: Un affiliato prevede di vendere fino a 70.000 azioni ordinarie, pari a circa lo 0,12% delle 57,7 milioni di azioni in circolazione. La vendita proposta, del valore di circa 4,35 milioni di dollari, sar脿 effettuata tramite Merrill Lynch alla NYSE intorno al 04 agosto 2025.
Le azioni sono state originariamente ottenute il 16 giugno 1995 tramite un conferimento in partnership. Negli ultimi tre mesi il dichiarante non ha venduto azioni. Il dichiarante certifica di non essere a conoscenza di informazioni materiali negative non divulgate.
Poich茅 l鈥檃vviso riguarda azioni secondarie gi脿 emesse, non vi 猫 alcuna diluizione per gli azionisti esistenti. Tuttavia, l鈥檕perazione potrebbe indicare l鈥檌ntenzione del detentore di ridurre l鈥檈sposizione; gli investitori potrebbero monitorare i prossimi Moduli 4 per ulteriori attivit脿 degli insider.
Scotts Miracle-Gro (SMG) 鈥� Presentaci贸n del Formulario 144: Un afiliado planea vender hasta 70,000 acciones comunes, lo que representa aproximadamente el 0.12% de las 57.7 millones de acciones en circulaci贸n. La venta propuesta, valorada en aproximadamente $4.35 millones, se realizar谩 a trav茅s de Merrill Lynch en la NYSE alrededor del 04 de agosto de 2025.
Las acciones fueron originalmente adquiridas el 16 de junio de 1995 mediante una contribuci贸n en sociedad. El declarante no ha vendido acciones en los 煤ltimos tres meses. El declarante certifica que no conoce informaci贸n material adversa no divulgada.
Dado que el aviso cubre acciones secundarias ya emitidas, no hay 诲颈濒耻肠颈贸苍 para los accionistas existentes. Sin embargo, la transacci贸n puede indicar el deseo del titular de reducir su exposici贸n; los inversores podr铆an estar atentos a futuros Formularios 4 para detectar actividad adicional de los insiders.
Scotts Miracle-Gro (SMG) 鈥� Form 144 鞝滌稖: 頃� 瓿勳棿靷皜 鞎� 5,700毵� 欤� 欷� 鞎� 0.12%鞐� 頃措嫻頃橂姅 斓滊寑 70,000欤检潣 氤错喌欤茧ゼ 毵る弰頃� 瓿勴殟鞛呺媹雼�. 鞝滌晥霅� 毵る弰 旮堨暋鞚� 鞎� 435毵� 雼煬鞚措┌, 2025雲� 8鞗� 4鞚�瓴� NYSE鞚� Merrill Lynch毳� 韱淀暣 鞁ろ枆霅� 鞓堨爼鞛呺媹雼�.
頃措嫻 欤检嫕鞚� 1995雲� 6鞗� 16鞚� 韺岉姼雱堨嫮 於滌瀽毳� 韱淀暣 觳橃潓 旆摑霅橃棃鞀惦媹雼�. 鞝滌稖鞛愲姅 歆�雮� 3臧滌洈臧� 欤检嫕鞚� 毵る弰頃橃 鞎婌晿鞙茧┌, 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵�鞝曥爜 鞝曤炒臧� 鞐嗢潓鞚� 鞚胳頃╇媹雼�.
氤� 瓿奠電� 鞚措 氚滍枆霅� 2彀� 欤检嫕鞐� 甏�頃� 瓴冹溂搿� 旮办〈 欤检＜霌れ棎 雽�頃� 頋劃 須臣電� 鞐嗢姷雼堧嫟. 雼る, 鞚措矆 瓯半灅電� 氤挫湢鞛愳潣 雲胳稖 於曥唽 鞚橂弰毳� 鞁滌偓頃� 靾� 鞛堨溂氙�搿� 韴瀽鞛愲摛鞚� 頄ロ泟 Form 4 鞝滌稖 雮挫棴鞚� 欤检嫓頃� 頃勳殧臧� 鞛堨姷雼堧嫟.
Scotts Miracle-Gro (SMG) 鈥� D茅p么t du formulaire 144 : Un affili茅 pr茅voit de vendre jusqu'脿 70 000 actions ordinaires, soit environ 0,12 % des 57,7 millions d'actions en circulation. La vente propos茅e, d'une valeur d'environ 4,35 millions de dollars, sera r茅alis茅e via Merrill Lynch 脿 la NYSE aux alentours du 4 ao没t 2025.
Les actions ont 茅t茅 initialement obtenues le 16 juin 1995 par une contribution en partenariat. Aucun titre n鈥檃 茅t茅 vendu par le d茅clarant au cours des trois derniers mois. Ce dernier certifie qu鈥檌l n鈥檃 connaissance d鈥檃ucune information mat茅rielle n茅gative non divulgu茅e.
脡tant donn茅 que l鈥檃vis concerne des actions secondaires d茅j脿 茅mises, il n鈥檡 a aucune dilution pour les d茅tenteurs actuels. Cependant, cette transaction peut indiquer la volont茅 du d茅tenteur de r茅duire son exposition ; les investisseurs pourraient surveiller les prochains formulaires 4 pour d茅tecter toute activit茅 suppl茅mentaire des initi茅s.
Scotts Miracle-Gro (SMG) 鈥� Form 144 Einreichung: Ein verbundenes Unternehmen plant den Verkauf von bis zu 70.000 Stammaktien, was etwa 0,12 % der 57,7 Millionen ausstehenden Aktien entspricht. Der geplante Verkauf im Wert von etwa 4,35 Millionen US-Dollar soll 眉ber Merrill Lynch an der NYSE um den 4. August 2025 durchgef眉hrt werden.
Die Aktien wurden urspr眉nglich am 16. Juni 1995 durch einen Partnerschaftsbeitrag erworben. In den letzten drei Monaten wurden vom Einreicher keine Aktien verkauft. Der Einreicher best盲tigt, dass keine nicht offengelegten wesentlichen negativen Informationen bekannt sind.
Da die Mitteilung sekund盲re, bereits ausgegebene Aktien betrifft, gibt es keine 痴别谤飞盲蝉蝉别谤耻苍驳 f眉r bestehende Aktion盲re. Die Transaktion k枚nnte jedoch den Wunsch des Inhabers signalisieren, seine Beteiligung zu reduzieren; Investoren sollten zuk眉nftige Form 4 Meldungen auf weitere Insideraktivit盲ten beobachten.
- No dilution: shares already outstanding; capital structure unchanged.
- Regulatory transparency: timely Rule 144 notice shows adherence to insider-sale disclosure rules.
- Potential negative signal: insider disposing of $4.35 m in stock could be interpreted as reduced confidence.
- Unidentified seller: absence of identity limits ability to gauge strategic importance of the sale.
Insights
TL;DR 鈥� Modest insider sale; minor impact given 0.12 % of shares.
70 k shares worth $4.35 m represent a small fraction of SMG鈥檚 float. The sale will not alter share count or capital structure, but insider selling can sometimes precede price weakness if viewed as a negative signal. Absent context on the seller鈥檚 role or broader selling patterns, I view the filing as informational rather than catalytic.
TL;DR 鈥� Insider liquidity event; governance risk minimal.
The Form 144 indicates compliance with Rule 144 disclosure. Lack of recent sales and the small percentage suggest routine diversification. Still, continuous monitoring of subsequent filings is prudent to detect any accelerated insider exit that might raise governance concerns.
Scotts Miracle-Gro (SMG) 鈥� Comunicazione Modulo 144: Un affiliato prevede di vendere fino a 70.000 azioni ordinarie, pari a circa lo 0,12% delle 57,7 milioni di azioni in circolazione. La vendita proposta, del valore di circa 4,35 milioni di dollari, sar脿 effettuata tramite Merrill Lynch alla NYSE intorno al 04 agosto 2025.
Le azioni sono state originariamente ottenute il 16 giugno 1995 tramite un conferimento in partnership. Negli ultimi tre mesi il dichiarante non ha venduto azioni. Il dichiarante certifica di non essere a conoscenza di informazioni materiali negative non divulgate.
Poich茅 l鈥檃vviso riguarda azioni secondarie gi脿 emesse, non vi 猫 alcuna diluizione per gli azionisti esistenti. Tuttavia, l鈥檕perazione potrebbe indicare l鈥檌ntenzione del detentore di ridurre l鈥檈sposizione; gli investitori potrebbero monitorare i prossimi Moduli 4 per ulteriori attivit脿 degli insider.
Scotts Miracle-Gro (SMG) 鈥� Presentaci贸n del Formulario 144: Un afiliado planea vender hasta 70,000 acciones comunes, lo que representa aproximadamente el 0.12% de las 57.7 millones de acciones en circulaci贸n. La venta propuesta, valorada en aproximadamente $4.35 millones, se realizar谩 a trav茅s de Merrill Lynch en la NYSE alrededor del 04 de agosto de 2025.
Las acciones fueron originalmente adquiridas el 16 de junio de 1995 mediante una contribuci贸n en sociedad. El declarante no ha vendido acciones en los 煤ltimos tres meses. El declarante certifica que no conoce informaci贸n material adversa no divulgada.
Dado que el aviso cubre acciones secundarias ya emitidas, no hay 诲颈濒耻肠颈贸苍 para los accionistas existentes. Sin embargo, la transacci贸n puede indicar el deseo del titular de reducir su exposici贸n; los inversores podr铆an estar atentos a futuros Formularios 4 para detectar actividad adicional de los insiders.
Scotts Miracle-Gro (SMG) 鈥� Form 144 鞝滌稖: 頃� 瓿勳棿靷皜 鞎� 5,700毵� 欤� 欷� 鞎� 0.12%鞐� 頃措嫻頃橂姅 斓滊寑 70,000欤检潣 氤错喌欤茧ゼ 毵る弰頃� 瓿勴殟鞛呺媹雼�. 鞝滌晥霅� 毵る弰 旮堨暋鞚� 鞎� 435毵� 雼煬鞚措┌, 2025雲� 8鞗� 4鞚�瓴� NYSE鞚� Merrill Lynch毳� 韱淀暣 鞁ろ枆霅� 鞓堨爼鞛呺媹雼�.
頃措嫻 欤检嫕鞚� 1995雲� 6鞗� 16鞚� 韺岉姼雱堨嫮 於滌瀽毳� 韱淀暣 觳橃潓 旆摑霅橃棃鞀惦媹雼�. 鞝滌稖鞛愲姅 歆�雮� 3臧滌洈臧� 欤检嫕鞚� 毵る弰頃橃 鞎婌晿鞙茧┌, 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵�鞝曥爜 鞝曤炒臧� 鞐嗢潓鞚� 鞚胳頃╇媹雼�.
氤� 瓿奠電� 鞚措 氚滍枆霅� 2彀� 欤检嫕鞐� 甏�頃� 瓴冹溂搿� 旮办〈 欤检＜霌れ棎 雽�頃� 頋劃 須臣電� 鞐嗢姷雼堧嫟. 雼る, 鞚措矆 瓯半灅電� 氤挫湢鞛愳潣 雲胳稖 於曥唽 鞚橂弰毳� 鞁滌偓頃� 靾� 鞛堨溂氙�搿� 韴瀽鞛愲摛鞚� 頄ロ泟 Form 4 鞝滌稖 雮挫棴鞚� 欤检嫓頃� 頃勳殧臧� 鞛堨姷雼堧嫟.
Scotts Miracle-Gro (SMG) 鈥� D茅p么t du formulaire 144 : Un affili茅 pr茅voit de vendre jusqu'脿 70 000 actions ordinaires, soit environ 0,12 % des 57,7 millions d'actions en circulation. La vente propos茅e, d'une valeur d'environ 4,35 millions de dollars, sera r茅alis茅e via Merrill Lynch 脿 la NYSE aux alentours du 4 ao没t 2025.
Les actions ont 茅t茅 initialement obtenues le 16 juin 1995 par une contribution en partenariat. Aucun titre n鈥檃 茅t茅 vendu par le d茅clarant au cours des trois derniers mois. Ce dernier certifie qu鈥檌l n鈥檃 connaissance d鈥檃ucune information mat茅rielle n茅gative non divulgu茅e.
脡tant donn茅 que l鈥檃vis concerne des actions secondaires d茅j脿 茅mises, il n鈥檡 a aucune dilution pour les d茅tenteurs actuels. Cependant, cette transaction peut indiquer la volont茅 du d茅tenteur de r茅duire son exposition ; les investisseurs pourraient surveiller les prochains formulaires 4 pour d茅tecter toute activit茅 suppl茅mentaire des initi茅s.
Scotts Miracle-Gro (SMG) 鈥� Form 144 Einreichung: Ein verbundenes Unternehmen plant den Verkauf von bis zu 70.000 Stammaktien, was etwa 0,12 % der 57,7 Millionen ausstehenden Aktien entspricht. Der geplante Verkauf im Wert von etwa 4,35 Millionen US-Dollar soll 眉ber Merrill Lynch an der NYSE um den 4. August 2025 durchgef眉hrt werden.
Die Aktien wurden urspr眉nglich am 16. Juni 1995 durch einen Partnerschaftsbeitrag erworben. In den letzten drei Monaten wurden vom Einreicher keine Aktien verkauft. Der Einreicher best盲tigt, dass keine nicht offengelegten wesentlichen negativen Informationen bekannt sind.
Da die Mitteilung sekund盲re, bereits ausgegebene Aktien betrifft, gibt es keine 痴别谤飞盲蝉蝉别谤耻苍驳 f眉r bestehende Aktion盲re. Die Transaktion k枚nnte jedoch den Wunsch des Inhabers signalisieren, seine Beteiligung zu reduzieren; Investoren sollten zuk眉nftige Form 4 Meldungen auf weitere Insideraktivit盲ten beobachten.
| (State or other jurisdiction of incorporation or organization) | (Commission File Number) | (IRS Employer Identification Number) | ||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Item 2.02 | Results of Operations and Financial Condition | ||||
Item 9.01 | Financial Statements and Exhibits | ||||
MSA SAFETY INCORPORATED | |||||||||||
(Registrant) | |||||||||||
By | /s/ Elyse L. Brody | ||||||||||
| Elyse L. Brody | |||||||||||
| Interim Chief Financial Officer | |||||||||||
Source:
FAQ
How many Scotts Miracle-Gro shares are being registered for sale?
What is the estimated market value of the shares?
When is the planned sale date for SMG stock?
Will this insider sale dilute existing SMG shareholders?
Where will the shares be sold and through which broker?
When were the shares originally acquired?
